Cargando…

Intravitreal Injection for Diabetic Macular Edema as Adjunctive Therapy for Proliferative Diabetic Retinopathy: A Retrospective Study

PURPOSE: To detect the impact of intravitreal injection (IVI) therapy with sole anti-vascular-endothelial-growth-factor (VEGF) or combined with steroids treating diabetic macular edema (DME) on activity of proliferative diabetic retinopathy (PDR) based on total number of panretinal photocoagulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aljundi, Wissam, Suffo, Shady, Munteanu, Cristian, Langenbucher, Achim, Seitz, Berthold, Abdin, Alaa Din
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765541/ https://www.ncbi.nlm.nih.gov/pubmed/35058686 http://dx.doi.org/10.2147/OPTH.S346065

Ejemplares similares

Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion
por: Aljundi, Wissam, et al.
Publicado: (2023)

Intravitreal aflibercept following treat and extend protocol versus fixed protocol for treatment of neovascular age-related macular degeneration
por: Abdin, Alaa Din, et al.
Publicado: (2021)

First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration
por: Abdin, Alaa Din, et al.
Publicado: (2022)

Recurrent fungal endophthalmitis after intravitreal injections of bevacizumab
por: Abdin, Alaa Din, et al.
Publicado: (2020)

Topical NSAIDs and Oral Acetazolamide for Macular Edema after Uncomplicated Phacoemulsification: Outcome and Predictors of Non-Response
por: Aljundi, Wissam, et al.
Publicado: (2022)

Penetrating Excimer Laser Keratoplasty with vs without the Homburg Cross-Stitch Marker in Inexperienced Surgeons
por: Suffo, Shady, et al.
Publicado: (2021)

The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy
por: Al-Kharashi, Abdullah, et al.
Publicado: (2016)

Laser Photocoagulation Combined with Intravitreal Triamcinolone Acetonide Injection in Proliferative Diabetic Retinopathy with Macular Edema
por: Choi, Kyung Seek, et al.
Publicado: (2007)

Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy
por: Zaman, Yawar, et al.
Publicado: (2013)

Macular Edema Formation and Deterioration of Retinal Function after Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy
por: Imai, Hisanori, et al.
Publicado: (2011)

Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice
por: Abdin, Alaa Din, et al.
Publicado: (2023)

Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy
por: Khodabandeh, Alireza, et al.
Publicado: (2018)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
por: Choi, Wungrak, et al.
Publicado: (2020)

Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
por: Gabr, Ahmed F., et al.
Publicado: (2023)

Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy
por: Graham, Patricia S., et al.
Publicado: (2018)

Single-dose Intravitreal Bevacizumab after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: an Effective Adjunctive Treatment
por: DEHGHANI, Alireza, et al.
Publicado: (2017)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
por: Marques, Ines P., et al.
Publicado: (2020)

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
por: Shakarchi, Faiz I, et al.
Publicado: (2018)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho, Giuliana, et al.
Publicado: (2020)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016)

Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
por: Someya, Hideaki, et al.
Publicado: (2019)

Assessing the Learning Curve for DMEK Using Post-Procedural Clinical Outcomes—Comparison of Four Different Surgeons during Two Different Periods
por: Stuhlmacher, Emilia Sophie, et al.
Publicado: (2023)

Effects of Intravitreal Aflibercept on Retinal Function and Improvement of Macular Edema Associated With Diabetic Retinopathy
por: Ichio, Atsushi, et al.
Publicado: (2020)

Triamcinolone and Bevacizumab as Adjunctive Therapies to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
por: Lopez-Lopez, F., et al.
Publicado: (2012)

Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
por: Rodrigues, Magna Vanessa, et al.
Publicado: (2023)

Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?
por: Arabi, Amir, et al.
Publicado: (2022)

Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis
por: Xie, Xiao, et al.
Publicado: (2023)

Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients
por: Andrés-Blasco, Irene, et al.
Publicado: (2023)

Vitreous Inflammatory Cytokines and Chemokines, Not Altered After Preoperative Adjunctive Conbercept Injection, but Associated With Early Postoperative Macular Edema in Patients With Proliferative Diabetic Retinopathy
por: Sun, Hongyan, et al.
Publicado: (2022)

Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
por: El-Batarny, Ashraf M
Publicado: (2007)

Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
por: Xu, Jun, et al.
Publicado: (2020)

Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review
por: Dervenis, Panagiotis, et al.
Publicado: (2021)

Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy
por: Wang, Weiwei, et al.
Publicado: (2023)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Intravitreal Therapy for Diabetic Macular Edema: An Update
por: Furino, Claudio, et al.
Publicado: (2021)

Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy
por: Guan, Jian, et al.
Publicado: (2020)

Vitreous inflammatory and angiogenic factors on patients with proliferative diabetic retinopathy or diabetic macular edema: the role of Lipocalin2
por: Batsos, Georgios, et al.
Publicado: (2022)

Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials
por: Do, Diana V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5o9eckcrcgq03ctvbla9fkco80